The function of PTB domain proteins

Slides:



Advertisements
Similar presentations
Protein Domains That Interact with Receptor Tyrosine Kinases: Structural Aspects Ming-Ming Zhou, Ph.D. MSSM Department of Pharmacology Course on “Cell.
Advertisements

Date of download: 7/5/2016 Copyright © 2016 McGraw-Hill Education. All rights reserved. Insulin signaling pathways. The insulin signaling pathways provide.
Date of download: 9/17/2016 Copyright © 2016 McGraw-Hill Education. All rights reserved. Schematic comparison of structural features of cell surface growth.
Schematic comparison of structural features of cell surface growth factor receptor tyrosine kinases and membrane-associated tyrosine kinase oncogene products.
The complex world of kidney microRNAs
Molecular regulation of mast cell activation
Hepatitis C Virus NS5A Protein–A Master Regulator?
Eph-Ephrin Bidirectional Signaling in Physiology and Disease
Sustaining Proliferative Signaling and Evading Growth Suppressors
The Cbl Family and Other Ubiquitin Ligases
Figure 2. Protein modules for the assembly of signaling complexes
All roads lead to FoxO Cell Metabolism
Important port for SHIP-1 at Dok-3
Characterizing Class I WW domains defines key specificity determinants and generates mutant domains with novel specificities  Jeremy Kasanov, Gregorio.
Ross Alexander Robinson, Xin Lu, Edith Yvonne Jones, Christian Siebold 
Kinase inhibitors: Vice becomes virtue
Role of HIPK2 in kidney fibrosis
Hepatitis C Virus NS5A Protein–A Master Regulator?
C2 Can Do It, Too Cell Volume 121, Issue 2, Pages (April 2005)
TGFβ Signaling: Receptors, Transducers, and Mad Proteins
Figure 1 Therapeutic targeting of the B-cell receptor (BCR)
Characterizing Class I WW domains defines key specificity determinants and generates mutant domains with novel specificities  Jeremy Kasanov, Gregorio.
Molecular regulation of mast cell activation
Bryan A. Whitson, MD, Blake A
Jing Zhang, Thomas M. Roberts, Ramesh A. Shivdasani  Gastroenterology 
Phoxy Lipids Cell Volume 105, Issue 7, Pages (June 2001)
EGFR T790M Mutation: A Double Role in Lung Cancer Cell Survival?
The gap junction protein connexin43 interacts with the second PDZ domain of the zona occludens-1 protein  Ben N.G. Giepmans, Wouter H. Moolenaar  Current.
Identification of TOR Signaling Complexes
WW domains Structure Volume 4, Issue 5, Pages (May 1996)
Secretin and vasoactive intestinal peptide receptors: Members of a unique family of G protein–coupled receptors  Charles D. Ulrich, Martin Holtmann‡,
Smads “Freeze” When They Ski
RASopathy Gene Mutations in Melanoma
Epidermal growth factor receptor signaling
Autophagy in kidney disease and aging: lessons from rodent models
Specificity in Signal Transduction
A Tripartite Protein Complex with the Potential to Couple Synaptic Vesicle Exocytosis to Cell Adhesion in Brain  Stefan Butz, Masaya Okamoto, Thomas C.
Structure of CheA, a Signal-Transducing Histidine Kinase
Signaling Interplay in Ras Superfamily Function
Volume 11, Issue 5, Pages (May 2003)
Ross Alexander Robinson, Xin Lu, Edith Yvonne Jones, Christian Siebold 
Volume 9, Issue 6, Pages (June 2011)
Volume 73, Issue 1, Pages 5-7 (January 2008)
Yuji Yamanashi, David Baltimore  Cell 
Volume 63, Issue 1, Pages 1-11 (January 2003)
Apoptosis: Letting Slip The Dogs Of War
Signalling links in the liver: Knitting SOCS with fat and inflammation
Crystal Structures of the BAR-PH and PTB Domains of Human APPL1
Antigen-Receptor Signaling to Nuclear Factor κB
The Conformational Plasticity of Protein Kinases
Volume 85, Issue 5, Pages (May 1996)
Volume 56, Issue 4, Pages (October 1999)
Volume 72, Issue 10, Pages (November 2007)
Role of macromolecular IgA in IgA nephropathy
Molecular mechanisms of renal hypertrophy: Role of p27Kip1
Mark A Lemmon, Kathryn M Ferguson, Joseph Schlessinger  Cell 
Immunoregulatory role of TNFα in inflammatory kidney diseases
SUR-8, a Conserved Ras-Binding Protein with Leucine-Rich Repeats, Positively Regulates Ras-Mediated Signaling in C. elegans  Derek S Sieburth, Qun Sun,
The Structure of JNK3 in Complex with Small Molecule Inhibitors
T cells and T-cell receptors in acute renal failure
Guilty as charged Cancer Cell
A new ‘tac’ for childhood nephrotic syndrome
Volume 7, Issue 1, Pages 1-11 (July 1997)
The NB-ARC domain: a novel signalling motif shared by plant resistance gene products and regulators of cell death in animals  Erik A. van der Biezen,
Brief Review – Growth Factors and Receptors
Cell Signaling by Receptor Tyrosine Kinases
The Cbl Family and Other Ubiquitin Ligases
Volume 95, Issue 2, Pages (October 1998)
Hildegard Büning, Arun Srivastava 
Notch and the Immune System
Presentation transcript:

The function of PTB domain proteins Ben Margolis, Jean-Paul Borg, Sam Straight, Debra Meyer  Kidney International  Volume 56, Issue 4, Pages 1230-1237 (October 1999) DOI: 10.1046/j.1523-1755.1999.00700.x Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 1 Peptide-binding sites for phosphotyrosine binding (PTB) domains. The name PTB is a misnomer, as PTB domains are involved in phosphotyrosine dependent and independent interactions. The letters in bold represent residues known to be involved in binding or conserved among PTB domain binding targets. These motifs in X11, EGFR (epidermal growth factor receptor), and IR (insulin receptor) are known to form β turn motifs. The Numb-binding partners in LNX and NAK (Numb-associated kinase) are also likely to form a β turn. The YIGPYL peptide that binds Numb was identified by screening a random peptide library with the Numb PTB domain. This peptide does not form a β turn, and its physiological relevance awaits further analysis[71]. Kidney International 1999 56, 1230-1237DOI: (10.1046/j.1523-1755.1999.00700.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 2 Schematic representation of proteins with phosphotyrosine-binding (PTB) domains. Two major groups of PTB domains have been identified: those with primary sequence similarity to the Shc PTB domain and those similar to the insulin receptor substrate (IRS) PTB domains. Many of these proteins have multiple protein–protein interaction domains indicating their role in nucleating protein complexes. Basic descriptions of these proteins are found in the text. The different domains displayed are: (a) SH2-Src homology 2 domain, a domain mediating phosphotyrosine-dependent interactions[7]. It was first identified in the Src tyrosine kinase. (b) PDZ-PSD95/discs-large/ZO-1 domain, a domain that can bind to the carboxy-terminus of proteins and that plays a role in protein clustering and targeting[57]. It is named after three proteins that were initially identified with this domain. (c) WW-tryptophan-tryptophan domain, a domain that can bind proline-rich sequences[72]. It is named after a conserved tryptophan repeat found within its sequence. (d) SH3-Src homology 3 domain, first identified in Src and binds proline-rich sequences such as WW domains[7]. (e) JBD-JNK binding domain, which binds the JNK serine threonine kinase. Thus far, this is the only protein with this domain[73]. (f) PH-pleckstrin homology domain, a domain first identified in pleckstrin a major protein kinase C substrate in platelets[17]. The best described function for PH domains is binding to phospholipids and phospholipid head groups. Kidney International 1999 56, 1230-1237DOI: (10.1046/j.1523-1755.1999.00700.x) Copyright © 1999 International Society of Nephrology Terms and Conditions

Figure 3 A heterotrimeric protein complex involved in protein targeting. In the worm C. elegans, Lin-2, Lin-7, and Lin-10 are necessary for proper targeting of the Let-23 growth factor receptor[62]. In mammalian cells, similar proteins have been identified[53],[55]. X11 proteins have also been referred to as Mints[54], whereas mlin-7 have been called Velisa[55]. These proteins have been found to form a heterotrimeric complex. The regions of the proteins involved in the interactions are indicated by horizontal brackets. CAMK, calmodulin kinase-like domain; GK, guanylate kinase domain. Other domains are defined in Figure 2. Kidney International 1999 56, 1230-1237DOI: (10.1046/j.1523-1755.1999.00700.x) Copyright © 1999 International Society of Nephrology Terms and Conditions